ClinicalTrials.Veeva

Menu

Detection of Asymptomatic Atrial Fibrillation in Persons of 65 Year of Age or Older (DETECT AF)

D

Diagram Research

Status

Completed

Conditions

Atrial Fibrillation

Treatments

Other: Subjects with asymptomatic atrial fibrillation will be screened by using a Mobile ECG Device

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Atrial fibrillation (AF) is the most common cardiac arrhythmia. Although the condition itself is not life-threatening, the complications result in increased morbidity and mortality. AF is often asymptomatic and a considerable number of people suffering from AF are not aware of their condition. Unfortunately, a cerebral infarction is often the first clinical manifestation. The idea to screen subjects opportunistically for Asymptomatic Atrial Fibrillation (AAF) was infeasible until recently. However, with a recently-developed smartphone connected Mobile ECG Device (MED), this seems to be feasible after all.

The main objectives are:

  • To examine the feasibility of screening subjects of ≥65 years old for AAF.
  • To validate the smartphone connected MED as an AAF screening instrument for application in transmural care in the Netherlands.

Full description

Study design:

Prospective validation study.

Enrollment

2,168 patients

Sex

All

Ages

65+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age ≥65 years
  • Is willing to give informed consent

Exclusion criteria

  • Known medical history with Atrial Fibrillation
  • Not mental competent

Trial design

2,168 participants in 1 patient group

Screening with Mobile ECG Device
Description:
Subjects with asymptomatic atrial fibrillation will be screened by using a Mobile ECG Device
Treatment:
Other: Subjects with asymptomatic atrial fibrillation will be screened by using a Mobile ECG Device

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems